| Scientific
Symposium Poster Presentations October 2003, Houston, Texas |
|
![]() Researchers discuss posters at the 2003 Scientific Symposium in Houston |
|
|
Blanche
Alter, MD, MPH |
National
Cancer Institute, Rockville, Maryland |
Cancer
Epidemiology in Fanconis Anemia: Lessons from the IBMFS |
|
Najim
Ameziane, MSc |
Vrije
Universiteit Medical Center, Amsterdam, The Netherlands |
Bi-allelic
Silencing of the Fanconi Anemia Gene FANCF in an AML Cell |
|
Chris
Mathew, PhD |
Kings
College, London, UK |
|
|
Philip
Rosenberg, PhD |
National
Cancer Institute, Rockville, Maryland |
|
|
Bhuvanesh
Singh, MD |
Memorial
Sloan-Kettering Cancer Center, New York |
|
Farid
Boulad, MD |
Memorial
Sloan-Kettering Cancer Center, New York |
|
|
Farid
Boulad, MD |
Memorial
Sloan-Kettering Cancer Center, New York |
|
|
Nupur
Gangopadhyay, DVM, PhD |
University
of Pittsburgh Cancer Institute, Pennsylvania |
Facilitation
of Allogenic Bone Marrow Derived Stem Cell Engraftment Utilizing |
|
Yigal
Dror, MD |
Hospital
for Sick Children, Toronto, Canada |
|
|
Jean-Hugues
Dalle, MD |
Hôpital
Sainte-Justine, Montreal, Canada |
Successful
Pregnancies After Bone Marrow Transplantation in a Fanconi Anemia
Patient |
|
Jerome
Larghero, PhD |
Hôpital
Sainte-Louis, Paris, France |
Stem
Cell Clonogenic Capacity in FA Patients is Linked to Somatic Mosaicism |
|
John
Wagner, MD |
University
of Minnesota, Minneapolis, Minnesota |
|
Menachem Bitan, MD
|
Hadassah
Hebrew University Hospital, Jerusalem, Israel |
|
Pooneh Heydari, MD
|
Tehran
University of Medical Science, Tehran, Iran |
Allogeneic
Blood and Marrow Transplantation in Fanconi Anemia: an Experience
of Iran |
Protein
Function: DNA Damage and Repair
Miriam
Ferrer, MSc
|
Vrije
University Medical Center, Amsterdam, The Netherlands |
|
Celine Jacquemont, PhD Student
|
Institute
Curie, Paris, France |
Global
Cellular Response to Specific DNA Damages of BRCA and FANC Mutated
Cells |
|
Nigel
Jones, PhD |
University
of Liverpool, UK |
|
Satoru Komaki, MD
|
Oregon
Health and Science University, Portland, Oregon |
S-Phase
Specific Hyper-Recombination Phenotype in Fanconi Anemia Cells |
|
Muriel
Lambert, PhD |
New
Jersey Medical School, Newark, New Jersey |
FANCA
and FANCG Interact Directly with Nonerythroid Alpha Spectrin II |
|
Stephen
Meyn, MD, FRCP(C) |
Hospital
for Sick Children, Toronto, Ontario, Canada |
FANCD2
Associates with BLM at Telomeres in ALT-Immortalized Human Cells |
|
Dora
Papadopoulo, PhD |
Institute
Curie, Paris, France |
Mutations
in FANC and BRCA Genes Compromise the Faithful Rejoining of Broken
DNA Ends |
Jordi Surrallés, PhD
|
Universitat
Autónoma de Barcelona, Bellaterra, Spain |
No
Role of the Fanconi Anaemia Gene FANCD2 in Normal Length Trinucleotide
Repeat Instability |
Andrei Thomashevski, PhD
|
University
of Virginia, Charlottesville, Virginia |
FA
Core Complex Exists in 4 Distinct Forms in Different Subcellular
Compartments |
Weidong
Wang, PhD
|
National
Institute on Aging, National Institutes of Health, Baltimore, Maryland |
|
Margaret
Zdzienicka, PhD
|
Leiden
University Medical Center, Leiden, The Netherlands |
|
Mark Brenneman, PhD
|
Rutgers
University, Piscataway, New Jersey |
|
Francesco
Galimi, MD, PhD |
The
Salk Institute, La Jolla, California |
Lentiviral-Mediated
Gene Correction of Human Hematopoietic Progenitors from Fanconi
Anemia Patients |
|
Peter
Kurre, MD |
Fred
Hutchinson Cancer Research Center, Seattle, Washington |
Phenotypic
Correction of Murine FANCC Deficient Hematopoietic Cells Using Foamy
Virus Vectors |
|
Anuj
Mankad, Graduate Student |
Oregon
Health and Science University, Portland, Oregon |
|
|
Meenakshi
Noll, PhD |
Oregon Health and Science University, Portland, Oregon |
In
Vivo
Hematopoietic Stem Cell Selection using Clinically Relevant Drugs
in Mouse Model of Fanconi Anemia Group A |
|
Kaoru
Yamada, PhD |
Mt.
Sinai School of Medicine, New York, New York |
|
Kathryn Leung, MD |
Baylor College of Medicine, Houston, Texas |
Fanconi
Anemia and Oxidative Stress: The FANCG Protein Interacts with Peroxiredoxin
3 |
Johnson Liu, MD
|
Mount Sinai School of Medicine, New York, New York |
Fanconi
Anemia and Phosphoinositide (PI) / Inositol Phosphate (IP) Signaling
Proteins |
|
Filippo Rosselli, PhD |
Institut Gustave Roussy, Villejuif, France |
TNF-a
Overproduction in Fanconi Anemia: Molecular Origins and Consequences |
Linda Sandercock, PhD
|
University of Calgary, Canada |
|
Robert Tebbs, PhD
|
Lawrence Livermore National Laboratory, Livermore,
California |
|
Giovanni Pagano, ScD |
Italian National Cancer Institute, Mercogliano, Italy |
Redox
Toxicity Mechanisms Characterize All Xenobiotics Involved in Excess
Toxicity to FA Cells |
Jun
Mi, PhD
|
University of Virginia, Charlottesville, Virginia |
|
|
W. Clark Lambert, MD, PhD |
New Jersey Medical School, Newark, New Jersey |
|
Johannes Rischewski, MD
|
University Hospital Eppendorf, Hamburg, Germany |
Mutation
Spectrum of FANCC in Europe and DHLPC-Based Identification of a
Large Deletion |
Akiko Shimamura, MD, PHD
|
Dana-Farber Cancer Institute, Boston, Massachusetts |
Mutational
Analysis of the Fanconi Anemia Complementation Group D2 Gene, FANCD2 |
Jean Soulier, MD, PhD
|
Hôpital Saint-Louis, Paris, France |
|
Stacie Stone, Graduate Student
|
Oregon Health and Science University, Portland, Oregon |
The
Fanconi Anemia Pathway is Functionally Conserved in Xenopus |
|
Elsa Callén Moréu, PhD Student |
Universitat Autònoma de Barcelona, Spain |
|
|
Henri van de Vrugt, PhD |
Vrije Universiteit, Amsterdam, The Netherlands |
|
|
Michael Wallisch, PhD |
Oregon Health and Science University, Portland, Oregon |
FANCA
is Spatially and Temporally Regulated During the Cell Cycle |